Advanced Search
WU Weizhang, CHANG Dongshu, ZHU Fuhai, WANG Yong. Dose Distribution of Body Gamma Rays Radiotherapy for Multiple Pulmonary Metastatic Tumor[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 391-394. DOI: 10.3971/j.issn.1000-8578.2014.04.024
Citation: WU Weizhang, CHANG Dongshu, ZHU Fuhai, WANG Yong. Dose Distribution of Body Gamma Rays Radiotherapy for Multiple Pulmonary Metastatic Tumor[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 391-394. DOI: 10.3971/j.issn.1000-8578.2014.04.024

Dose Distribution of Body Gamma Rays Radiotherapy for Multiple Pulmonary Metastatic Tumor

More Information
  • Received Date: February 03, 2013
  • Revised Date: June 26, 2013
  • Objective To investigate the dose distribution of OUR-QGD whole body γ rays radiotherapy for multiple pulmonary metastatic tumor and evaluate its safety and feasibility. Methods Twenty cases of lung metastatic tumor, with 9-12 foci and diameter≤2.3 cm,were treated with OUR-QGD whole body γ rays radiotherapy. Twelve cases were supine and eight cases were prone. Gross target volume(GTV) was delineated in lung window, and 5 mm was enlarged as planning target volume (PTV).50% isodose line was around PTV and 70% isodose line was around 90% of GTV.The reference dose was defi ned as 50% isodose line with 4 Gy per fraction, and the prescribed dose was 52 Gy with 13 fractions. The dose distribution was evaluated by dose volume histogram (DVH). Results 52 Gy of body γ rays radiotherapy to 90% of GTV was equivalent to 94 Gy of conventional radiotherapy to 90% of GTV. The average dose for total lung of the supine patients was 8.36 Gy, and V20, V10 and V5 for total lung were 12.6%, 24.60% and 37.40%, respectively. The average dose for total lung of the prone patients was 8.57 Gy, and V20, V10 and V5 were 12.67%, 25.10% and 40.40%, respectively. Conclusion As to physical dosage, OUR-QGD whole body γ rays radiotherapy is safe and feasible for patients with multiple pulmonary metastatic tumor.
  • [1]
    Suit H,Skates S,Taghian A,et al.Clinical implications of heterogeneity of tumor response to radiation therapy[J].Radiother Oncol,1992, 25(4):251-60.
    [2]
    DeVita VT,Hellman S,Rosenberg SA.Cancer:principles and practice of oncology [M].5th ed.Philadelphia:Lippincott,1997: 25 2-606.
    [3]
    Okunieff P,Petersen AL,Philip A,et al.Stereotactic Body Radiation Therapy (SBRT) for lung metastases[J].Acta Oncologica,2006, 45 (7): 808-17.
    [4]
    Wu SX,Deng ML,Bao Y,et al.Therapeutic analysis of stereotactic radiotherapy for 39 patients with lung metastasis[J].Ai Zheng, 20 06,25(7): 880-4.[吴绍雄,邓美玲,包勇,等.39例肺转移瘤立体 定向放射治疗的疗效分析[J].癌症, 2006,25(7):880-4.]
    [5]
    Xiao JP,Xu GZ,Zhang HZ,et al.Stereotactic radiotherapy for pulmonary metastatic neoplasm-preliminary experience[J]. Zhonghua Fang She Zhong Liu Xue Za Zhi,2006,15(1): 23-7.[肖 建平,徐国镇,张红志,等. 肺转移瘤立体定向放疗初探[J].中华放 射肿瘤学杂志,2006,15(1):23-7.]
    [6]
    Yu JM,Guo SF,Li JB,et al.Analysis of 30 cases with lung metastases treated by fractionated stereotactic radiotherapy[J].Lin Chuang Fei Ke Za Zhi,2002,7(1):21-3.[于金明,郭守芳,李建彬, 等.肺转移瘤体部X刀立体定向放射治疗30例分析[J].临床肺科 杂志, 2002,7(1):21-3.]
    [7]
    Xia T,Li H,Sun Q,et al.Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II nonsmall- cell lung cancer[J].Int J Radiat Oncol Biol Phys,2006, 66 (1):117-25.
    [8]
    Zheng RH,Ge D,Shi MX.Surgical treatment and prognosis of pulmonary metastasis[J].Zhonghua Jie He He Hu Xi Za Zhi,2002, 25 (4): 214-7.[郑如恒, 葛棣,石美鑫.转移性肺癌的外科治疗及预 后影响因素[J].中华结核和呼吸杂志,2002, 25(4): 214-7.]
  • Related Articles

    [1]SHAO Shengli, WANG Jiheng, LIU Shanting. Application and Thinking of Deep Learning in Predicting Lateral Cervical Lymph Node Metastasis of Papillary Thyroid Cancer[J]. Cancer Research on Prevention and Treatment, 2025, 52(1): 36-41. DOI: 10.3971/j.issn.1000-8578.2025.24.0761
    [2]HUANG Xiangping, WU Ling, TAN Chaochao. Serum Metabonomics Study of Difference in Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on LC-MS[J]. Cancer Research on Prevention and Treatment, 2023, 50(10): 974-980. DOI: 10.3971/j.issn.1000-8578.2023.23.0038
    [3]DUAN Yongheng, ZHOU Lingdan, GAO Jian, LIN Sheng, ZHANG Linghua, GU Xueying, ZENG Xuchun, HONG Wenxu, DUAN Shan, HUANG Zijian. Relationship of Expression Difference of miR-658 and miR-492 with Pelvic Lymph Node Metastasis from Squamous Carcinoma of Cervix[J]. Cancer Research on Prevention and Treatment, 2016, 43(8): 699-703. DOI: 10.3971/j.issn.1000-8578.2016.08.010
    [4]SUN Ronghao, LI Chao, FAN Jinchuan, WANG Shaoxin, WANG Wei, LIU Kun, LAN Xiaojiao, HE Yuxin. Relationship of Tumor Location and Other Clinicopathological Features with Differentiated Thyroid Cancer with Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2014, 41(09): 993-997. DOI: 10.3971/j.issn.1000-8578.2014.09.009
    [5]ZENG Jin-yan. A Meta Analysis of Relationship between COX-2 Expression and Lymph Node Metastasis in Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(05): 584-587. DOI: 10.3971/j.issn.1000-8578.2011.05.028
    [6]WU Di, ZHANG Hao, LIU Cai-gang, LU Ping. Result of Risk Factors for Para aortic Lymph Node Metastasis of Gastric Cancer Based on Hospital Population of Two Decades[J]. Cancer Research on Prevention and Treatment, 2010, 37(11): 1273-1276. DOI: 10.3971/j.issn.1000-8578.2010.11.016
    [7]CHEN Yi-feng, ZHANG Bai-ling, HUANG Yun-peng, LIAN Yun-zong. Relationship between Expression of hPF4mRNA, Concentration of Plasma PF4 and Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 162-162. DOI: 10.3971/j.issn.1000-8578.2010.02.010
    [8]QIN Ri-sheng. Analysis of 28 Cases Nasopharyngeal Carcinoma with Distant Metastasis Within 2 Years[J]. Cancer Research on Prevention and Treatment, 2005, 32(09): 585-586. DOI: 10.3971/j.issn.1000-8578.1612
    [9]ZHOU Hong-yan, DIAO Lu-ming, CHEN Ying, DENG Hao, LIU Li-jiang. Relationship of the Expression of MMP-2 、MMP-9 、TIMP-1 with Lymph Node Metastasis and Survival Time in Gastric Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2005, 32(05): 274-275. DOI: 10.3971/j.issn.1000-8578.1272
    [10]PEI Feng, FENG Mao-hui, YANG Guo-Liang, et al. The Relationship Between the Expression of nm23-H1 and Lymph Node Metastasis in Colorectal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2000, 27(05): 385-386. DOI: 10.3971/j.issn.1000-8578.192

Catalog

    Article views (1315) PDF downloads (874) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return